These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8481363)

  • 21. Retinal changes associated with tamoxifen treatment for breast cancer.
    Murray DC; Gibson JM
    Eye (Lond); 1998; 12 ( Pt 3a)():485-6. PubMed ID: 9775258
    [No Abstract]   [Full Text] [Related]  

  • 22. The Author's Response: Assessment of Breast Cancer Patients' Knowledge and Decisional Conflict Regarding Tamoxifen Use.
    Kim SI; Lim MC; Lee ES
    J Korean Med Sci; 2016 Apr; 31(4):647. PubMed ID: 27051254
    [No Abstract]   [Full Text] [Related]  

  • 23. Tamoxifen-associated eye disease. A review.
    Nayfield SG; Gorin MB
    J Clin Oncol; 1996 Mar; 14(3):1018-26. PubMed ID: 8622006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for ocular toxicity in asymptomatic patients treated with tamoxifen.
    Kalina RE; Wells CG
    Am J Ophthalmol; 1995 Jan; 119(1):112-3. PubMed ID: 7825684
    [No Abstract]   [Full Text] [Related]  

  • 25. Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients.
    Malfetano JH
    Gynecol Oncol; 1990 Oct; 39(1):82-4. PubMed ID: 2132556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients.
    Pavlidis NA; Petris C; Briassoulis E; Klouvas G; Psilas C; Rempapis J; Petroutsos G
    Cancer; 1992 Jun; 69(12):2961-4. PubMed ID: 1591689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The eyes have it! Tamoxifen maculopathy revisited: a case report.
    Nair AG; Das D; Goyal A; Gandhi RA
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):640-2. PubMed ID: 22731242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen for breast cancer: associated endometrial cancer.
    Gusberg SB
    Cancer; 1990 Apr; 65(7):1463-4. PubMed ID: 2311060
    [No Abstract]   [Full Text] [Related]  

  • 29. Ocular toxicity in low-dose tamoxifen: a prospective study.
    Noureddin BN; Seoud M; Bashshur Z; Salem Z; Shamseddin A; Khalil A
    Eye (Lond); 1999 Dec; 13 ( Pt 6)():729-33. PubMed ID: 10707134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen and hypercalcaemia. A case report.
    Bezwoda WR; Derman D; Zaltzman M; de Moor NG; Lange M
    S Afr Med J; 1980 Nov; 58(20):821-2. PubMed ID: 6255614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gynecologic complications associated with long-term adjuvant tamoxifen therapy for breast cancer.
    Wolf DM; Jordan VC
    Gynecol Oncol; 1992 May; 45(2):118-28. PubMed ID: 1592278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal manipulation and gynaecological cancer: the tamoxifen dilemma.
    Ross D; Whitehead M
    Curr Opin Obstet Gynecol; 1995 Feb; 7(1):63-8. PubMed ID: 7742519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Birdshot chorioretinopathy associated with tamoxifen retinal toxicity].
    Sommer S; Badet JC; Zaoui M; Naoun-Hubert I; Rozot P
    J Fr Ophtalmol; 2000 May; 23(5):494-7. PubMed ID: 10844311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endometriosis in tamoxifen therapy].
    Fuith LC; Pflanzl W
    Geburtshilfe Frauenheilkd; 1995 Jun; 55(6):354-5. PubMed ID: 7657147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tamoxifen and endometrial cancer.
    Jordan VC
    Lancet; 1988 Oct; 2(8618):1019. PubMed ID: 2902449
    [No Abstract]   [Full Text] [Related]  

  • 36. Tamoxifen retinopathy: a rare but serious complication.
    Bentley CR; Davies G; Aclimandos WA
    BMJ; 1992 Feb; 304(6825):495-6. PubMed ID: 1312376
    [No Abstract]   [Full Text] [Related]  

  • 37. [Breast cancer: can tamoxifen, under certain conditions, have adverse effects?].
    Cosset JM; Burtin P
    Bull Cancer; 1991; 78(8):685-6. PubMed ID: 1932836
    [No Abstract]   [Full Text] [Related]  

  • 38. Risks and benefits of tamoxifen therapy.
    Assikis VJ; Jordan VC
    Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):21-3. PubMed ID: 9065923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gynaecological complications of women treated with tamoxifen for breast cancer.
    Dew JE; Eden JA
    Aust N Z J Obstet Gynaecol; 1995 May; 35(2):198-200. PubMed ID: 7677689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypercalcaemia after tamoxifen for breast cancer.
    Rees GJ
    Br Med J; 1979 Dec; 2(6204):1590. PubMed ID: 534902
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.